U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. For Consumers
  3. Women's Health
  4. Women's Health Research
  5. OWH-Funded Research
  6. Extramural Research – Women’s Health
  1. OWH-Funded Research

Extramural Research – Women’s Health

From the FDA Office of Women's Health

Image
Young woman working on laptop

On this page: Areas of interest | BAA funding | CERSIs 

OWH-funded extramural research 

OWH supports scientific research to advance the science of women’s health in the form of grants, cooperative agreements, or contracts.

Areas of interest

The Women’s Health Research Roadmap provides a framework for continuing to integrate women’s health science into all of FDA’s research activities, including information about priority areas for OWH-funded research. 

BAA funding

Extramural research at FDA is primarily funded through a Broad Agency Announcement (BAA). The FDA BAA is open to all responsible sources, and small businesses are strongly encouraged to respond. Offerors may include single entities or teams from private sector organizations, Federally Funded Research and Development Centers (FFRDCs), and/or academic institutions. 

CERSIs

FDA Centers of Excellence in Regulatory Science and Innovation (CERSIs) are collaborations between FDA and academic institutions to advance regulatory science through innovative research, training, and scientific exchanges. OWH works with various CERSIs to fund research projects. 

Current OWH-funded CERSI projects

Funding YearCERSIPROJECT
FY20CERSI- UCSF-StanfordIdentifying genetic mechanisms of doxorubicin-induced cardiotoxicity 
FY21CERSI- Yale-MayoSex differences in immune profiles of post-acute sequelae of SARS-CoV-2 infection (PASC) before and after vaccination 
FY21CERSI- UCSF-StanfordLearning real-world sex-specific clinical factors influencing the susceptibility to infection, immune response, treatment utilization and outcomes among individuals infected with SARS-CoV-2 infection  
FY22CERSI- Yale-MayoEvaluate the application of machine learning algorithms to the management of postpartum hemorrhage 
FY22CERSI- Yale-MayoImproving the diagnosis and treatment of women with myocardial ischemia and no obstructive coronary artery disease 
FY22CERSI- UMEvaluating quality performance of extemporaneously compounded estrogen hormone products

Learn more 

If you have questions about OWH extramural research, please contact FDA Office of Women's Health at fda-owh@fda.hhs.gov. 

Back to Top